Sfoglia per AUTORE
FERRAù F
Collezione AOU San Luigi di Orbassano

  

Items : 5

Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study. in Frontiers in oncology / Front Oncol. 2024 Jul 9;14:1436588. doi: 10.3389/fonc.2024.1436588. eCollection 2024.
2024
AOU San Luigi di Orbassano

Sposito M; Belluomini L; Nocini R; Insolda J; Scaglione IM; Menis J; Simbolo M; Lugini A; Buzzacchino F; Verderame F; Spinnato F; Aprile G; Calvetti L; Occhipinti M; Marinelli D; Veccia A; Lombardo F; Soto Parra HJ; Ferraù F; Savastano C; Porta C; Pradelli L; Sicari E; Castellani S; Malapelle U; Novello S; Bria E; Pilotto S; Milella M; et alii...

Are comorbidities of patients with adrenal incidentaloma tied to sex? in Frontiers in endocrinology / Front Endocrinol (Lausanne). 2024 May 14;15:1385808. doi: 10.3389/fendo.2024.1385808. eCollection 20
2024
AOU San Luigi di Orbassano

Puglisi S; Bara? Neki? A; Morelli V; Alessi Y; Fosci M; Pani A; Zibar Tomsic K; Palmieri S; Ferraù F; Pia A; Chiodini I; Kastelan D; Reimondo G; Terzolo M;

Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical Carcinoma. in Cancers / Cancers (Basel). 2020 Mar 20;12(3):740. doi: 10.3390/cancers12030740.
2020
AOU San Luigi di Orbassano

Puglisi S; Calabrese A; Basile V; Ceccato F; Scaroni C; Altieri B; Della Casa S; Loli P; Pivonello R; De Martino MC; Canu L; Russo M; Badalamenti G; Torlontano M; Stigliano A; Ferraù F; Arnaldi G; Saba L; Quirino A; Perotti P; Berchialla P; Terzolo M;

Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer. in Future oncology (London, England) / Future Oncol. 2019 Apr;15(10):1115-1123. doi: 10.2217/fon-2018-0715. Epub 2019 Mar 19.
2019
AOU San Luigi di Orbassano

Caffo O; Facchini G; Biasco E; Ferraù F; Morelli F; Donini M; Buttigliero C; Calvani N; Guida A; Chiuri VE; Basso U; Mucciarini C; Conteduca V; Rossetti S; Veccia A; Maines F; Kinspergher S; De Giorgi U;

Phase II randomized study of vandetanib plus gemcitabine or gemcitabine plus placebo as first-line treatment of advanced non-small-cell lung cancer in elderly patients. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2014 May;9(5):733-7. doi: 10.1097/JTO.0000000000000120.
2014
AOU San Luigi di Orbassano

Gridelli C; Novello S; Zilembo N; Luciani A; Favaretto AG; De Marinis F; Genestreti G; Crinò L; Grossi F; Caffo O; Ferraù F; Cruciani G; Brandes AA; Galetta D; Barni S; Fasola G; Cerea G; Ferrari S; Iannacone C; Ciardiello F;